Outcome of 313 Czech Patients With IgA Nephropathy After Renal Transplantation.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2021
Historique:
received: 16 06 2021
accepted: 03 09 2021
entrez: 18 10 2021
pubmed: 19 10 2021
medline: 12 1 2022
Statut: epublish

Résumé

The recurrence of IgA nephropathy (IgAN) after kidney transplantation occurs in 20-35% of patients. The main aim of this study is to evaluate risk factors affecting the course of IgAN after renal biopsy of native kidney and kidney transplant. We evaluated clinical parameters and histological findings at the time of biopsy of native kidney and after kidney transplantation in 313 patients with IgAN with a follow-up of up to 36 years. Using hierarchical clustering method, patients with graft failure (n=50) were divided into two groups based on the mean time from kidney transplant to graft failure (11.2

Identifiants

pubmed: 34659212
doi: 10.3389/fimmu.2021.726215
pmc: PMC8515028
doi:

Types de publication

Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

726215

Informations de copyright

Copyright © 2021 Maixnerova, Hruba, Neprasova, Bednarova, Slatinska, Suchanek, Kollar, Novak, Tesar and Viklicky.

Déclaration de conflit d'intérêts

JN is a co-founder and co-owner of and consultant for Reliant Glycosciences, LLC, and a co-inventor on US patent application 14/318,082 (assigned to UAB Research Foundation). The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Kidney Int. 2017 Aug;92(2):461-469
pubmed: 28601198
Am J Kidney Dis. 2012 Jun;59(6):865-73
pubmed: 22497792
Am J Kidney Dis. 2002 Mar;39(3):493-502
pubmed: 11877568
Clin Transplant. 2005;19 Suppl 14:41-8
pubmed: 15955168
Nephrol Dial Transplant. 2012 Jun;27(6):2553-8
pubmed: 22167589
Nat Genet. 2011 Mar 13;43(4):321-7
pubmed: 21399633
Pathol Int. 2004 Nov;54(11):837-42
pubmed: 15533226
J Am Soc Nephrol. 2017 Feb;28(2):691-701
pubmed: 27612994
Kidney Int. 2007 Jun;71(11):1148-54
pubmed: 17342176
Am J Transplant. 2019 Oct;19(10):2855-2864
pubmed: 31017369
J Clin Lab Anal. 2015 Sep;29(5):353-60
pubmed: 25131157
BMC Nephrol. 2018 Dec 3;19(1):344
pubmed: 30509213
Nephrol Dial Transplant. 2013 May;28(5):1070-3
pubmed: 23674835
J Am Soc Nephrol. 2011 Oct;22(10):1795-803
pubmed: 21949093
N Engl J Med. 2002 Jul 11;347(2):103-9
pubmed: 12110738
Nephrol Dial Transplant. 1994;9(3):309-12
pubmed: 8052439
Transplant Proc. 2007 Oct;39(8):2595-6
pubmed: 17954186
Kidney Int. 2009 Sep;76(5):546-56
pubmed: 19571790
Transplantation. 1982 Feb;33(2):241-6
pubmed: 7036478
Am J Kidney Dis. 1996 Jul;28(1):99-104
pubmed: 8712229
J Am Soc Nephrol. 2007 Dec;18(12):3177-83
pubmed: 17978307
Am J Nephrol. 2017;45(2):99-106
pubmed: 28056461
Kidney Int. 2010 Feb;77(3):181-6
pubmed: 19924103
PLoS One. 2018 Apr 25;13(4):e0196101
pubmed: 29694420
Kidney Int. 2001 Nov;60(5):1948-54
pubmed: 11703614
Kidney Int. 2003 Jun;63(6):2286-94
pubmed: 12753320
Clin Transplant. 1997 Apr;11(2):127-33
pubmed: 9113449
PLoS One. 2016 Sep 09;11(9):e0162044
pubmed: 27611091
Int J Mol Sci. 2020 Nov 28;21(23):
pubmed: 33260613
Transpl Int. 2010 Feb;23(2):169-75
pubmed: 19761553
Kidney Int. 2009 Sep;76(5):534-45
pubmed: 19571791
Kidney Int. 2016 Jan;89(1):167-75
pubmed: 26759049
J Ren Nutr. 2014 May;24(3):200-7
pubmed: 24759301
Kidney Int. 2017 May;91(5):1014-1021
pubmed: 28341274
N Engl J Med. 2002 Sep 5;347(10):738-48
pubmed: 12213946
Annu Rev Med. 2013;64:339-56
pubmed: 23072577
N Engl J Med. 2013 Jun 20;368(25):2402-14
pubmed: 23782179
Transplantation. 1997 Nov 27;64(10):1493-6
pubmed: 9392321
Front Immunol. 2019 Jun 19;10:1332
pubmed: 31275309
Nephrol Dial Transplant. 2013 May;28(5):1305-14
pubmed: 23229925
Clin Transplant. 1999 Aug;13(4):313-7
pubmed: 10485372
Nephrol Dial Transplant. 2003 Nov;18(11):2399-404
pubmed: 14551373
J Am Soc Nephrol. 2017 Jun;28(6):1943-1950
pubmed: 28255003

Auteurs

Dita Maixnerova (D)

Department of Nephrology, General Teaching Hospital, 1st Faculty of Medicine, Prague, Czech Republic.

Petra Hruba (P)

Department of Nephrology, Institute of Clinical and Experimental Medicine, Prague, Czech Republic.

Michaela Neprasova (M)

Department of Nephrology, General Teaching Hospital, 1st Faculty of Medicine, Prague, Czech Republic.

Kamila Bednarova (K)

Department of Nephrology, Institute of Clinical and Experimental Medicine, Prague, Czech Republic.

Janka Slatinska (J)

Department of Nephrology, Institute of Clinical and Experimental Medicine, Prague, Czech Republic.

Miloslav Suchanek (M)

University of Jan Evangelista Purkyně in Ústí nad Labem, Ústí nad Labem, Czech Republic.

Marek Kollar (M)

Department of Pathology, Institute of Clinical and Experimental Medicine, Prague, Czech Republic.

Jan Novak (J)

Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, United States.

Vladimir Tesar (V)

Department of Nephrology, General Teaching Hospital, 1st Faculty of Medicine, Prague, Czech Republic.

Ondrej Viklicky (O)

Department of Nephrology, Institute of Clinical and Experimental Medicine, Prague, Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH